Gary Osaka

Pharmacokinetics, Tissue Distribution, and Expression Efficiency of Plasmid [33P]DNA Following Intravenous Administration of DNA/Cationic Lipid Complexes in Mice: Use of a Novel Radionuclide Approach

Gary Osaka, Kendall D. Carey, Andrew G. S. Cuthbertson et al. · Journal of Pharmaceutical Sciences · 1996 · 104 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Development of a humanized disulfide-stabilized anti-p185HER2 Fv-beta-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug.

Maria Luı́sa Rodrigues, Leonard G. Presta, Claire E. Kotts et al. · PubMed · 1995 · 78 citations

Pharmacy, Oncology, Pharmacology +17

Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler

Boonsri Ongpipattanakul, Tue H. Nguyen, Thomas F. Zioncheck et al. · Journal of Biomedical Materials Research · 1997 · 46 citations

Engineering, Bioengineering, Surgery +17

Pharmacokinetics and Interspecies Scaling of Recombinant Human Factor VIII

Joyce Mordenti, Gary Osaka, Kit Garcia et al. · Toxicology and Applied Pharmacology · 1996 · 40 citations

Medicine, Hematology, Pharmacokinetics +12

Engineering linear F(ab')₂ fragments for efficient production in <i>Escherichia coli</i> and enhanced antiproliferative activity

Gerardo Zapata, John Brady Ridgway, Joyce Mordenti et al. · Protein Engineering Design and Selection · 1995 · 22 citations

Pharmacy, Biochemistry, Molecular Biology +17